Table of Contents

• 1.   Market Introduction
  •   1. Objectives of the Study
      2. Market Definition
      3. Market Scope
       3.1 . Years Considered for the Study
       3.2 . Market Covered
      4. Currency
      5. Limitations
      6. Stakeholders
    
• 2.   Research Tracking Typeology
  •   1. Research Data
       1.1 . Secondary Data
        1.1.1 . Key Data from Secondary Sources
       1.2 . Primary Data
        1.2.1. Key Data from Primary Sources
      2. Market Size Estimation
      3. Market Breakdown and Data Triangulation
      4. Assumptions for the Study
    
• 3.   Executive Summary
  •   1. Market Outlook
      2. Segment Outlook
      3. Competitive Insights
    
• 4.   Single-Cell Multi-Omics Market Variables, Trends and Scope

  •   1. Market Lineage Outlook
      2. Penetration and Growth Prospect Mapping
      3. Industry Value Chain Analysis
      4. Cost Analysis Breakdown
      5. Technology Overview
      6. Regulatory Framework
       6.1. Reimbursement Framework
       6.2. Standards and Compliances

• 5.   Market Overview
  •   1. Market Dynamics
       1.1. Market Driver Analysis
        1.1.1. Increasing focus of Single-Cell Multi-Omics Companies on Brand Protection
        1.1.2. Untapped Opportunities in Emerging Regions
       1.2. Market Restraint Analysis
        1.2.1. High Cost Associated with Implementation of Predictive Analysis
       1.3. Industry Challenges
        1.3.1. Presence of Ambiguous Regulatory Framework
    
• 6.   Single-Cell Multi-Omics Market Analysis Tools
  •   1. Industry Analysis - Porter’s
       1.1. Supplier Power
       1.2. Buyer Power
       1.3. Substitution Threat
       1.4. Threat from New Entrants
       1.5. Competitive Rivalry
      2. Pestel Analysis
       2.1. Political Landscape
       2.2. Environmental Landscape
       2.3. Social Landscape
       2.4. Technology Landscape
       2.5. Legal Landscape
      3. Major Deals And Strategic Alliances Analysis
       3.1. Joint Ventures
       3.2. Mergers and Acquisitions
       3.3. Licensing and Partnership
       3.4. Technology Collaborations
       3.5. Strategic Divestments
      4. Market Entry Strategies
      5. Case Studies
    
• 7.   Single-Cell Multi-Omics Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Single Cell Genomics
      2. Single Cell Transcriptomics and Proteomics
      3. Single Cell Metabolomics

• 8.   Single-Cell Multi-Omics Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Instruments
       1.1. Flow Cytometers/FACS Instruments
       1.2. Next-Generation Sequencing Systems
       1.3. Polymerase Chain Reaction
       1.4. Microscopes
       1.5. Microarray Systems
       1.6. Spectrophotometers
       1.7. Microplate Readers
       1.8. Cell Counters
       1.9. Cell sorters
       1.10. Others
      2. Consumables
       2.1. Beads
       2.2. Microplates
       2.3. Assay kits
       2.4. Reagents
       2.5. Others

• 9.   Single-Cell Multi-Omics Market, By Workflow Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Single Cell Isolation
       1.1. Flow Cytometry/FACS
       1.2. Manual Cell Picking
       1.3. Magnetic-activated Cell Sorting
       1.4. Laser Microdissection
       1.5. Random seeding/ Limiting Dilution
       1.6. Microfluidics
       1.7. Others
      2. Single Cell Preparation
       2.1. Microfluidics
       2.2. Whole genome amplification
       2.3. Single Cell RNA-seq
       2.4. Others
      3. Single Cell Analysis
       3.1. Polymerase Chain Reaction
       3.2. Next Generation Sequencing
       3.3. Microarray
       3.4. Multiple Displacement Amplification
       3.5. Multiple Annealing and Looping-based Amplification Cycles (MALBAC)
       3.6. Flow Cytometry
       3.7. Mass Spectrometry
       3.8. Microscopy (Fluorescence, Phase and Bright Field)
       3.9. Microfluidics
       3.10. Others
        3.10.1. In-Vitro Transcription
        3.10.2. phi29 DNA Polymerase
         3.10.2.1. MA
         3.10.2.2. TTA

• 10.   Single-Cell Multi-Omics Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Research and Academic Laboratories
      2. Biopharmaceutical and Biotech Companies
      3. Others (Hospitals, Clinics, and Diagnostic Labs)

• 11.   Single-Cell Multi-Omics Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

  •   1. Oncology
      2. Immunology
      3. Neurology
      4. Microbiology
      5. Stem Cell
      6. Cell Biology
      7. Others

• 12.   North America Single-Cell Multi-Omics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. U.S.A
       2.2. Canada
       2.3. Mexico
      3. Market Size (USD Million) Forecast for North America 2023-2031

• 13.   Latin America Single-Cell Multi-Omics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Brazil
       2.2. Venezuela
       2.3. Argentina
       2.4. Rest of Latin America
      3. Market Size (USD Million) Forecast for Latin America 2023-2031

• 14.   Europe Single-Cell Multi-Omics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Germany
       2.2. U.K
       2.3. France
       2.4. Italy
       2.5. Spain
       2.6. Russia
       2.7. Poland
       2.8. Rest of Europe
      3. Market Size (USD Million) Forecast for Europe 2023-2031

• 15.   Asia Pacific Single-Cell Multi-Omics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. Japan
       2.2. China
       2.3. India
       2.4. Australia and New Zealand
       2.5. ASEAN
       2.6. Rest of Asia Pacific
      3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

• 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

  •   1. Introduction
      2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
       2.1. GCC
       2.2. Israel
       2.3. South Africa
       2.4. Rest of MEA
      3. Market Size (USD Million) Forecast for MEA 2023-2031

• 17.   Market Share Analysis and Competitive Landscape
  •   1. Global Landscape - Key Players, Revenue and Presence
      2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
      3. Global Emerging Companies
      4. North America - Market Share Analysis and Key Regional Players
      5. Europe - Market Share Analysis and Key Regional Players
      6. Asia Pacific - Market Share Analysis and Key Regional Players
      7. Global Key Player - Growth Matrix
    
• 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Offerings Offered and Financial Layouts)

  •   1. 1CellBio
       1.1. Company Overview
       1.2. Product Portfolio
       1.3. SWOT Analysis
       1.4. Financial Overview
       1.5. Strategic Overview
      2. 10x Genomics Inc.
       2.1. Company Overview
       2.2. Product Portfolio
       2.3. SWOT Analysis
       2.4. Financial Overview
       2.5. Strategic Overview
      3. Becton, Dickinson and Company
       3.1. Company Overview
       3.2. Product Portfolio
       3.3. SWOT Analysis
       3.4. Financial Overview
       3.5. Strategic Overview
      4. Bio-Rad Laboratories, Inc.
       4.1. Company Overview
       4.2. Product Portfolio
       4.3. SWOT Analysis
       4.4. Financial Overview
       4.5. Strategic Overview
      5. BGI Genomics Co. Ltd.
       5.1. Company Overview
       5.2. Product Portfolio
       5.3. SWOT Analysis
       5.4. Financial Overview
       5.5. Strategic Overview
      6. Celsee Inc.
       6.1. Company Overview
       6.2. Product Portfolio
       6.3. SWOT Analysis
       6.4. Financial Overview
       6.5. Strategic Overview
      7. Fluidigm Corporation
       7.1. Company Overview
       7.2. Product Portfolio
       7.3. SWOT Analysis
       7.4. Financial Overview
       7.5. Strategic Overview
      8. Fluxion Biosciences
       8.1. Company Overview
       8.2. Product Portfolio
       8.3. SWOT Analysis
       8.4. Financial Overview
       8.5. Strategic Overview
      9. GE
       9.1. Company Overview
       9.2. Product Portfolio
       9.3. SWOT Analysis
       9.4. Financial Overview
       9.5. Strategic Overview
      10. Mission Bio
       10.1. Company Overview
       10.2. Product Portfolio
       10.3. SWOT Analysis
       10.4. Financial Overview
       10.5. Strategic Overview
      11. NanoString Technologies, Inc.
       11.1. Company Overview
       11.2. Product Portfolio
       11.3. SWOT Analysis
       11.4. Financial Overview
       11.5. Strategic Overview
      12. Illumina, Inc.
       12.1. Company Overview
       12.2. Product Portfolio
       12.3. SWOT Analysis
       12.4. Financial Overview
       12.5. Strategic Overview
      13. PerkinElmer, Inc.
       13.1. Company Overview
       13.2. Product Portfolio
       13.3. SWOT Analysis
       13.4. Financial Overview
       13.5. Strategic Overview
      14. Qiagen N.V.
       14.1. Company Overview
       14.2. Product Portfolio
       14.3. SWOT Analysis
       14.4. Financial Overview
       14.5. Strategic Overview
      15. Takara Bio, Inc.
       15.1. Company Overview
       15.2. Product Portfolio
       15.3. SWOT Analysis
       15.4. Financial Overview
       15.5. Strategic Overview

• 19.   Pre and Post COVID-19 Impact

  •   1. Positive influence on the healthcare industry
      2. The financial disruption of the manufacturing sector
      3. Impact of COVID-19 on emerging companies
      4. Significant mandates in the healthcare regulations initiated by
                administrations
      5. The overall economic slowdown of the developing and developed nations

• 20.   FutureWise SME Key Takeaway Points for Client